# NAGPA

## Overview
The NAGPA gene encodes the enzyme N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase, commonly referred to as the uncovering enzyme (UCE). This enzyme is a type I transmembrane glycoprotein that plays a pivotal role in the lysosomal enzyme-targeting pathway by facilitating the generation of the mannose-6-phosphate (M6P) recognition signal, which is crucial for directing lysosomal hydrolases to lysosomes (Kang2012A; Coutinho2012Mannose6phosphate). Structurally, the NAGPA protein is characterized by several domains, including a catalytic domain and a cysteine-rich C-terminal domain, and it functions as a dimer (Gorelik2020Crystal). Mutations in the NAGPA gene have been linked to nonsyndromic persistent stuttering, highlighting its clinical significance (Kang2010Mutations). Despite its critical role in cellular processes, the full implications of NAGPA mutations in disease pathogenesis are still under investigation.

## Structure
The NAGPA protein, also known as N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase, is a transmembrane enzyme located on the luminal side of the trans-Golgi network. It consists of several domains: an N-terminal signal peptide, an inhibitory propeptide, a catalytic domain, a cysteine-rich C-terminal domain (CTD), a transmembrane segment, and a short cytoplasmic portion (Gorelik2020Crystal). The catalytic domain adopts a globular fold with three antiparallel beta sheets forming a distorted triangular prism, and it contains three N-linked glycans and three disulfide bonds (Gorelik2020Crystal). The propeptide blocks the active site by stretching along a groove on the catalytic domain, forming a 1,200-Å² interface primarily through polar contacts (Gorelik2020Crystal).

The CTD is characterized as flexible or disordered with an elongated shape, forming a long flexible stem that extends the catalytic domain away from the Golgi membrane (Gorelik2020Crystal). Structural analysis revealed that the full-length NAGPA crystallizes as a dimer, with the CTDs emerging from the same side of the catalytic domain dimer (Gorelik2020Crystal). The enzyme's structure is unique among vertebrate proteins but shares a structural family with enzymes in lower organisms (Gorelik2020Crystal).

## Function
The NAGPA gene encodes the enzyme N-acetylglucosamine-1-phosphodiester α-N-acetylglucosaminidase, commonly referred to as the uncovering enzyme (UCE). This enzyme plays a critical role in the lysosomal enzyme-targeting pathway by facilitating the generation of the mannose-6-phosphate (M6P) recognition signal. The M6P signal is essential for directing lysosomal hydrolases to lysosomes, where they perform crucial functions in cellular waste processing and recycling (Kang2012A; Coutinho2012Mannose6phosphate).

In healthy human cells, the uncovering enzyme is involved in the second step of M6P synthesis. Initially, GlcNAc-phosphotransferase attaches GlcNAc-1-P to mannose residues on acid hydrolases. The uncovering enzyme then removes the GlcNAc, exposing the M6P signal, which is recognized by M6P receptors in the trans-Golgi network. This recognition facilitates the packaging of hydrolases into vesicles for delivery to endosomes and lysosomes (Kang2012A; Coutinho2012Mannose6phosphate).

The uncovering enzyme is a type I transmembrane glycoprotein that cycles between the trans-Golgi network and the plasma membrane. It is synthesized as an inactive precursor and becomes active upon proteolytic cleavage by the endoprotease furin (Coutinho2012Mannose6phosphate).

## Clinical Significance
Mutations in the NAGPA gene have been implicated in nonsyndromic persistent stuttering, a speech disorder with a genetic component. Studies have identified several mutations in NAGPA among individuals with stuttering, including a change from arginine to cysteine at position 328, a change from histidine to glutamine at position 84, and a 16-bp deletion leading to an extended open reading frame. These mutations were not found in control subjects, suggesting a potential link to stuttering (Kang2010Mutations). 

The NAGPA gene is also associated with lysosomal enzyme-targeting pathways, and its mutations can affect the mannose-6-phosphate targeting signal pathway. However, unlike mutations in GNPTAB and GNPTG, which are linked to mucolipidosis types II and III, mutations in NAGPA have not been directly associated with these lysosomal storage disorders (Kang2010Mutations; Raza2015Mucolipidosis).

Additionally, certain intronic variants in NAGPA, such as rs1001171T>A, have been predicted to have potentially damaging effects and are linked to altered gene expression, which may contribute to stuttering (Sylvester2022Determination). Despite these associations, the exact role of NAGPA mutations in disease pathogenesis remains to be fully elucidated.

## Interactions
The N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase (NAGPA) protein primarily interacts with its substrates, N-acetylglucosamine (GlcNAc) and mannose 6-phosphate (M6P), through specific hydrogen bonds and salt bridges. These interactions are crucial for its enzymatic activity, as the propeptide of NAGPA blocks the phosphate-binding site, preventing substrate binding until it is cleaved, allowing a conformational change that facilitates substrate interaction (Gorelik2020Crystal).

NAGPA forms dimers through its catalytic domain, with dimerization facilitated by a 1,100-Å² interface stabilized by hydrogen bonds and hydrophobic contacts. This dimeric configuration is conserved across species, as observed in the crystal structures of guinea pig and zebrafish NAGPA catalytic domains (Gorelik2020Crystal).

The presence of a cysteine-rich C-terminal domain (CTD) in NAGPA reduces the relative inhibition of the enzyme by its propeptide, suggesting a looser interaction when the CTD is present. A peptide derived from a conserved region of the propeptide can inhibit the enzyme in trans, with similar inhibition levels regardless of the presence of the CTD (Gorelik2020Crystal). Specific interactions with other proteins or nucleic acids are not detailed in the provided context.


## References


[1. (Sylvester2022Determination) Charles Sylvester, Rajesh Kundapur, and Santosh Maruthy. Determination of regulatory motifs and pathogenicity of intronic variants of gnptab, gnptg, and nagpa genes in individuals with stuttering. Bulletin of the National Research Centre, December 2022. URL: http://dx.doi.org/10.1186/s42269-022-00971-1, doi:10.1186/s42269-022-00971-1. This article has 0 citations.](https://doi.org/10.1186/s42269-022-00971-1)

[2. (Raza2015Mucolipidosis) M Hashim Raza, Carlos E F Domingues, Ronald Webster, Eduardo Sainz, Emily Paris, Rachel Rahn, Joanne Gutierrez, Ho Ming Chow, Jennifer Mundorff, Chang-soo Kang, Naveeda Riaz, Muhammad A R Basra, Shaheen Khan, Sheikh Riazuddin, Danilo Moretti-Ferreira, Allen Braun, and Dennis Drayna. Mucolipidosis types ii and iii and non-syndromic stuttering are associated with different variants in the same genes. European Journal of Human Genetics, 24(4):529–534, July 2015. URL: http://dx.doi.org/10.1038/ejhg.2015.154, doi:10.1038/ejhg.2015.154. This article has 33 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/ejhg.2015.154)

[3. (Kang2010Mutations) Changsoo Kang, Sheikh Riazuddin, Jennifer Mundorff, Donna Krasnewich, Penelope Friedman, James C. Mullikin, and Dennis Drayna. Mutations in the lysosomal enzyme–targeting pathway and persistent stuttering. New England Journal of Medicine, 362(8):677–685, February 2010. URL: http://dx.doi.org/10.1056/NEJMoa0902630, doi:10.1056/nejmoa0902630. This article has 325 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1056/NEJMoa0902630)

[4. (Gorelik2020Crystal) Alexei Gorelik, Katalin Illes, and Bhushan Nagar. Crystal structure of the mannose-6-phosphate uncovering enzyme. Structure, 28(4):426-436.e3, April 2020. URL: http://dx.doi.org/10.1016/j.str.2020.02.001, doi:10.1016/j.str.2020.02.001. This article has 6 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.str.2020.02.001)

[5. (Kang2012A) Changsoo Kang and Dennis Drayna. A role for inherited metabolic deficits in persistent developmental stuttering. Molecular Genetics and Metabolism, 107(3):276–280, November 2012. URL: http://dx.doi.org/10.1016/j.ymgme.2012.07.020, doi:10.1016/j.ymgme.2012.07.020. This article has 24 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.ymgme.2012.07.020)

[6. (Coutinho2012Mannose6phosphate) Maria Francisca Coutinho, Maria João Prata, and Sandra Alves. Mannose-6-phosphate pathway: a review on its role in lysosomal function and dysfunction. Molecular Genetics and Metabolism, 105(4):542–550, April 2012. URL: http://dx.doi.org/10.1016/j.ymgme.2011.12.012, doi:10.1016/j.ymgme.2011.12.012. This article has 192 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.ymgme.2011.12.012)